Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study | Online Medical Assistant Training Programs

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study | Online Medical Assistant Training Programs

https://onlinemedicalassistantprogramsedu.wordpress.com/2016/11/08/soluble-urokinase-plasminogen-activator-receptor-supar-in-acute-care-a-strong-marker-of-disease-presence-and-severity-readmission-and-mortality-a-retrospective-cohort-study/





Objective



Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker associated with presence and progression of disease and with increased risk of mortality. We aimed to evaluate the unspecific biomarker suPAR as a prognostic marker in patients admitted to acute care.



Methods



This registry-based retrospective cohort study included 4343 consecutively admitted patients from the Acute Medical Unit at a large Danish university…

To learn more visit: Emergency Medicine Journal current issue



The post Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study appeared first on Online Medical Assistant Training Programs.





Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study